Node-negative Breast Cancer
6 clinical trials · Condition
◉ Watch Node-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer (NCT05150652) | Irada Ibrahim-zada | 2022-02-18 |
| De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade (NCT04675827) | Jules Bordet Institute | 2022-01-17 |
| A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (NCT04569747) | Dana-Farber Cancer Institute | 2021-01-11 |
| A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older (NCT02823262) | Beth Israel Deaconess Medical Center | 2016-07-01 |
| Antioxidant Supplements, Genetics and Chemotherapy Outcomes (NCT03413761) | Roswell Park Cancer Institute | 2004-12-18 |
Track Node-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.